Literature DB >> 29233828

E2F1 interacts with BCL-xL and regulates its subcellular localization dynamics to trigger cell death.

Céline Vuillier1, Steven Lohard1, Aurélie Fétiveau1, Jennifer Allègre2, Cémile Kayaci2, Louise E King3, Frédérique Braun1, Sophie Barillé-Nion1, Fabien Gautier1,4, Laurence Dubrez2, Andrew P Gilmore3, Philippe P Juin5,4, Laurent Maillet5.   

Abstract

E2F1 is the main pro-apoptotic effector of the pRB-regulated tumor suppressor pathway by promoting the transcription of various pro-apoptotic proteins. We report here that E2F1 partly localizes to mitochondria, where it favors mitochondrial outer membrane permeabilization. E2F1 interacts with BCL-xL independently from its BH3 binding interface and induces a stabilization of BCL-xL at mitochondrial membranes. This prevents efficient control of BCL-xL over its binding partners, in particular over BAK resulting in the induction of cell death. We thus identify a new, non-BH3-binding regulator of BCL-xL localization dynamics that influences its anti-apoptotic activity.
© 2017 The Authors.

Entities:  

Keywords:  BCL‐2 family; BCL‐xL mobility; E2F1; apoptosis

Mesh:

Substances:

Year:  2017        PMID: 29233828      PMCID: PMC5797968          DOI: 10.15252/embr.201744046

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  32 in total

1.  Regulation of mitochondrial apoptotic events by p53-mediated disruption of complexes between antiapoptotic Bcl-2 members and Bim.

Authors:  Jie Han; Leslie A Goldstein; Wen Hou; Brian R Gastman; Hannah Rabinowich
Journal:  J Biol Chem       Date:  2010-04-19       Impact factor: 5.157

2.  Cytosol-to-membrane redistribution of Bax and Bcl-X(L) during apoptosis.

Authors:  Y T Hsu; K G Wolter; R J Youle
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

3.  Tight Sequestration of BH3 Proteins by BCL-xL at Subcellular Membranes Contributes to Apoptotic Resistance.

Authors:  Jessie Pécot; Laurent Maillet; Janic Le Pen; Céline Vuillier; Sophie de Carné Trécesson; Aurélie Fétiveau; Kristopher A Sarosiek; Florian J Bock; Frédérique Braun; Anthony Letai; Stephen W G Tait; Fabien Gautier; Philippe P Juin
Journal:  Cell Rep       Date:  2016-12-20       Impact factor: 9.423

Review 4.  Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics.

Authors:  Jean-Claude Martinou; Richard J Youle
Journal:  Dev Cell       Date:  2011-07-19       Impact factor: 12.270

5.  Cellular inhibitor of apoptosis protein-1 (cIAP1) can regulate E2F1 transcription factor-mediated control of cyclin transcription.

Authors:  Jessy Cartier; Jean Berthelet; Arthur Marivin; Simon Gemble; Valérie Edmond; Stéphanie Plenchette; Brice Lagrange; Arlette Hammann; Alban Dupoux; Laurent Delva; Béatrice Eymin; Eric Solary; Laurence Dubrez
Journal:  J Biol Chem       Date:  2011-06-08       Impact factor: 5.157

6.  E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction.

Authors:  J K Hsieh; S Fredersdorf; T Kouzarides; K Martin; X Lu
Journal:  Genes Dev       Date:  1997-07-15       Impact factor: 11.361

7.  DNA-binding independent cell death from a minimal proapoptotic region of E2F-1.

Authors:  L A Bell; J O'Prey; K M Ryan
Journal:  Oncogene       Date:  2006-05-01       Impact factor: 9.867

8.  The C-terminal helix of Bcl-x(L) mediates Bax retrotranslocation from the mitochondria.

Authors:  F Todt; Z Cakir; F Reichenbach; R J Youle; F Edlich
Journal:  Cell Death Differ       Date:  2012-10-19       Impact factor: 15.828

9.  E2F-1- and E2Ftr-mediated apoptosis: the role of DREAM and HRK.

Authors:  Hongying Hao; Canming Chen; Xiao-Mei Rao; Jorge G Gomez-Gutierrez; H Sam Zhou; Kelly M McMasters
Journal:  J Cell Mol Med       Date:  2012-03       Impact factor: 5.310

10.  Constitutive p53 heightens mitochondrial apoptotic priming and favors cell death induction by BH3 mimetic inhibitors of BCL-xL.

Authors:  J Le Pen; L Maillet; K Sarosiek; C Vuillier; F Gautier; S Montessuit; J C Martinou; A Letaï; F Braun; P P Juin
Journal:  Cell Death Dis       Date:  2016-02-04       Impact factor: 8.469

View more
  5 in total

1.  Down-regulation of lncRNA MEG3 promotes chronic low dose cadmium exposure-induced cell transformation and cancer stem cell-like property.

Authors:  Hsuan-Pei Lin; Matthew Rea; Zhishan Wang; Chengfeng Yang
Journal:  Toxicol Appl Pharmacol       Date:  2021-09-11       Impact factor: 4.219

Review 2.  Targeting of BCL-2 Family Members during Anticancer Treatment: A Necessary Compromise between Individual Cell and Ecosystemic Responses?

Authors:  Sophie Barillé-Nion; Steven Lohard; Philippe P Juin
Journal:  Biomolecules       Date:  2020-07-25

Review 3.  Keeping Cell Death Alive: An Introduction into the French Cell Death Research Network.

Authors:  Gabriel Ichim; Benjamin Gibert; Sahil Adriouch; Catherine Brenner; Nathalie Davoust; Solange Desagher; David Devos; Svetlana Dokudovskaya; Laurence Dubrez; Jérôme Estaquier; Germain Gillet; Isabelle Guénal; Philippe P Juin; Guido Kroemer; Patrick Legembre; Romain Levayer; Stéphen Manon; Patrick Mehlen; Olivier Meurette; Olivier Micheau; Bernard Mignotte; Florence Nguyen-Khac; Nikolay Popgeorgiev; Jean-Luc Poyet; Muriel Priault; Jean-Ehrland Ricci; Franck B Riquet; Santos A Susin; Magali Suzanne; Pierre Vacher; Ludivine Walter; Bertrand Mollereau
Journal:  Biomolecules       Date:  2022-06-28

4.  Dual targeting of BCL2 and MCL1 rescues myeloma cells resistant to BCL2 and MCL1 inhibitors associated with the formation of BAX/BAK hetero-complexes.

Authors:  Carolane Seiller; Sophie Maiga; Cyrille Touzeau; Céline Bellanger; Charlotte Kervoëlen; Géraldine Descamps; Laurent Maillet; Philippe Moreau; Catherine Pellat-Deceunynck; Patricia Gomez-Bougie; Martine Amiot
Journal:  Cell Death Dis       Date:  2020-05-05       Impact factor: 8.469

5.  Crosstalk between histone modification and DNA methylation orchestrates the epigenetic regulation of the costimulatory factors, Tim‑3 and galectin‑9, in cervical cancer.

Authors:  Li Zhang; Sijuan Tian; Meili Pei; Minyi Zhao; Li Wang; Yifan Jiang; Ting Yang; Juan Zhao; Lihua Song; Xiaofeng Yang
Journal:  Oncol Rep       Date:  2019-10-24       Impact factor: 3.906

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.